Literature DB >> 33429822

Clinical analysis of a patient simultaneously positive for antibodies of myelin oligodendrocyte glycoprotein and anti-N-methyl-D-aspartate receptor: A case report.

Liming Cao1,2, Lijie Ren2,3, Xuming Huang4.   

Abstract

RATIONALE: Myelin oligodendrocyte glycoprotein (MOG) antibody (MOG-Ab) disease (MOG-AD) is a type of demyelinating disease of the central nervous system characterized by a high frequency of optic neuritis (ON) attacks. anti-Nmethyl-D-aspartate receptor (NMDAR) encephalitis (anti-NMDARe) is an autoimmune disorder characterized by memory deficits, conscious disturbance, and seizures. Cases of simultaneous occurrence of MOG-Ab and anti-NMDARe antibody (anti-NMDARe-Ab) are rarely reported and could be mistaken for overlapping MOG-antibody disease (MOG-AD) and NMDARe. The diagnosis of such patients is challenging. PATIENT CONCERNS: We report the case of a 37-year-old man who presented with recurrent headaches for 3 months and worsening symptoms over 2 weeks. He had a history of ON. He had a generalized seizure after 7 days in the hospital. DIAGNOSIS: Brain magnetic resonance imaging (MRI) and cerebrospinal fluid tests showed no apparent abnormalities. Repeat MRI showed slight lesions 7 days later, and cerebrospinal fluid tests showed the simultaneous occurrence of MOG-Ab and anti-NMDARe-Ab.
INTERVENTIONS: He completely recovered after treatment with low doses of oral corticosteroids. OUTCOMES: Two months and 2 years follow-up showed that his condition was stable. LESSONS: The co-occurrence of MOG-Ab and anti-NMDAR-Ab does not indicate the co-occurrence of MOG-AD and anti-NMDARe. Laboratory findings should be combined with the clinical features to achieve an accurate and suitable diagnosis.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33429822      PMCID: PMC7793424          DOI: 10.1097/MD.0000000000024234

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  16 in total

1.  Auto-immune anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: three case reports.

Authors:  Fahad A Bashiri; Abdulrahman A Al-Rasheed; Saeed M Hassan; Muddathir H A Hamad; Heba Y El Khashab; Amal Y Kentab; Fahad B AlBadr; Mustafa A Salih
Journal:  Paediatr Int Child Health       Date:  2016-06-22       Impact factor: 1.990

2.  Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong.

Authors:  Alvin Chi-Chung Ho; Sophelia Hoi-Shan Chan; Eric Chan; Sheila Suet-Na Wong; Sharon Tsui-Hang Fung; Sharon Wan-Wah Cherk; Eva Lai-Wah Fung; Kam-Hung Ma; Kwing-Wan Tsui; Eric Kin-Cheong Yau; Virginia Chun-Nei Wong
Journal:  Brain Dev       Date:  2018-03-26       Impact factor: 1.961

3.  Long-term outcome of a group of Japanese children with myelin-oligodendrocyte glycoprotein encephalomyelitis without preventive immunosuppressive therapy.

Authors:  Naomi Hino-Fukuyo; Kazuhiro Haginoya; Toshiyuki Takahashi; Ichiro Nakashima; Kazuo Fujihara; Yoshiki Takai; Manami Akasaka; Shigeo Kure
Journal:  Brain Dev       Date:  2019-07-04       Impact factor: 1.961

4.  An unusual case of anti-MOG CNS demyelination with concomitant mild anti-NMDAR encephalitis.

Authors:  Jiajia Zhou; Winwen Tan; Suyin Elaine Tan; Jing Hu; Zhongqin Chen; Kang Wang
Journal:  J Neuroimmunol       Date:  2018-04-06       Impact factor: 3.478

5.  Repeated anti-N-methyl-D-aspartate receptor encephalitis coexisting with anti-myelin oligodendrocyte glycoprotein antibody-associated diseases: A case report.

Authors:  Shingo Aoe; Yohei Kokudo; Tadayuki Takata; Hideki Kobara; Mitsutoshi Yamamoto; Tetsuo Touge; Kazushi Deguchi; Tsutomu Masaki
Journal:  Mult Scler Relat Disord       Date:  2019-08-03       Impact factor: 4.339

6.  Clinical characteristics of myelin oligodendrocyte glycoprotein antibody neuromyelitis optica spectrum disorder.

Authors:  Sara Salama; Santiago Pardo; Michael Levy
Journal:  Mult Scler Relat Disord       Date:  2019-02-22       Impact factor: 4.339

7.  [A case of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-N-methyl-D-aspartate (NMDA) receptor antibody-positive encephalitis with optic neuritis].

Authors:  Satoshi Nagata; Yuji Nishimura; Kunihiko Mitsuo
Journal:  Rinsho Shinkeigaku       Date:  2018-09-29

8.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

9.  Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease.

Authors:  Carlos A Pérez; Paunel Agyei; Bhanu Gogia; Rebecca Harrison; Rohini Samudralwar
Journal:  J Neuroimmunol       Date:  2019-12-06       Impact factor: 3.478

Review 10.  Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.

Authors:  Siyuan Fan; Yan Xu; Haitao Ren; Hongzhi Guan; Feng Feng; Xuehui Gao; Ding Ding; Fang Fang; Guangliang Shan; Tianjia Guan; Yao Zhang; Yi Dai; Ming Yao; Bin Peng; Yicheng Zhu; Liying Cui
Journal:  Mult Scler Relat Disord       Date:  2018-01-31       Impact factor: 4.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.